Company intelligence / Profile preview

Helium Capital

London, England, United Kingdomhelium.capital ↗

Ownership: Private
Development stage: Other

Overview

Helium Capital is a private investment company focused on long-term, high-quality investments in public and private markets worldwide. It does not manage third-party capital or offer advisory services. The firm invests across asset classes but specifically avoids businesses involved in weapons production and restricts fossil fuel holdings to those transitioning toward clean energy. There are no indications of direct involvement in healthcare, biotech, pharma, or life sciences sectors.

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships reported

Beyond the preview

Go deeper on Helium Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helium Capital.

Explore the full profile